高级检索
迟东升, 凌文华, 马静, 夏敏, 候孟君, 王庆, 朱惠莲, 唐志红, 余小平. MnSOD 9Ala/Val基因多态性与冠心病的关系[J]. 中国公共卫生, 2006, 22(9): 1078-1080. DOI: 10.11847/zgggws2006-22-09-33
引用本文: 迟东升, 凌文华, 马静, 夏敏, 候孟君, 王庆, 朱惠莲, 唐志红, 余小平. MnSOD 9Ala/Val基因多态性与冠心病的关系[J]. 中国公共卫生, 2006, 22(9): 1078-1080. DOI: 10.11847/zgggws2006-22-09-33
CHI Dongsheng, LING Wenhua, MA Jing, . Association between manganese superoxide dismutase(MnSOD)9 Ala/Val genetic polymorphisms and coronary artery disease[J]. Chinese Journal of Public Health, 2006, 22(9): 1078-1080. DOI: 10.11847/zgggws2006-22-09-33
Citation: CHI Dongsheng, LING Wenhua, MA Jing, . Association between manganese superoxide dismutase(MnSOD)9 Ala/Val genetic polymorphisms and coronary artery disease[J]. Chinese Journal of Public Health, 2006, 22(9): 1078-1080. DOI: 10.11847/zgggws2006-22-09-33

MnSOD 9Ala/Val基因多态性与冠心病的关系

Association between manganese superoxide dismutase(MnSOD)9 Ala/Val genetic polymorphisms and coronary artery disease

  • 摘要:
      目的   探讨锰超氧化物歧化酶9 Ala/Val(MnSOD9 Ala/Val)基因多态性与冠心病、总超氧化物歧化酶(T-SOD)和锰超氧化物歧化酶(MnSOD)活性以及丙二醛(MDA)浓度的关系。
      方法   采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法检测262例冠心病患者和100例对照组的MnSOD9 Ala/Val基因多态性的基因型, 采用比色法测定血浆T-SOD、MnSOD活性以及MDA浓度。
      结果   与对照组比较, 冠心病患者的血浆T-SOD和MnSOD活性(23.61±16.51)U/ml与(44.01±22.68)U/ml, P < 0.001和(21.56±13.11)U/ml与(28.79±8.65)U/ml, P < 0.001明显降低, MDA浓度显著增高(2.47±0.73), (2.15±0.55)nmol/ml, P < 0.01;冠心病患者的MnSOD 9 AA基因型和A等位基因频率较对照组明显增多(64.2%与43.0%, P=0.001和80.0%与67.0%, P=0.014);MnSODAA基因型的MnSOD活牲较VV基因型明显降低(22.87±13.47)与(32.04±9.19)U/ml, P < 0.01); MnSOD与MDA负相关(r=-0.15, P < 0.01)。
      结论   冠心病患者的血浆T-SOD和MnSOD活性明显降低, MDA浓度显著增高; MnSOD 9 Ala/Val基因多态性AA基因型的血浆MnSOD活性降低。

     

    Abstract:
      Objective   To study the associations between manganese super oxide dismutase 9 Ala~Val genetic polymorphisms(MnSOD9 Ala/Val)and coronary artery disease(CAD), plasma activities of total superoxide dismutase(T-SOD), Mn-SOD, as well as plasma concentration of maleic dialdehyde(MDA).
      Methods   Using PCR-RFLP method to identify genotype of MnSOD9 Ala/Val genetic polymor phisms, and using colorimetry to detect plasma activities of T-SOD, MnSOD and plasma concentration of MDA in 262 CAD patients and 100 controls.
      Results   Compared with controls, the plasma act ivities of TSOD and MnSOD reduced obviously(23.61±16.51)U/ml vs(44.01±22.68)U/ml and(21.56±13.11)U/ml vs(28.79 ±8.65)U/ml, P < 0.001 andP < 0.001, respectively), while plasma MDAco ncentration in creased markedly(2.47± 0.73)nmol/ml vs(2.15±0.55)nmol/ml, P < 0.01).There were more AA genoty pe and A allele of MnSOD 9 Ala/Val genetic polymorphisms(64.2% vs 43.0%, P < 0.001 and 80.0% vs 67.0%, P=0.014, respectively)than controls in CAD patients.The activ ity of plasma MnSOD depressed in individuals with MnSOD AA genotype compared with those with VV genotype(22.87±13.47 vs 32.04±9.19 U/ml, P < 0.01).MnSOD correlated negatively with MDA(r=-0.15, P < 0.01).
      Conclusion   The plasma activities of T-SOD and MnSOD reduce obviously, in contrary, plasma concentration of MDA increases mar kedly in CADpat ients.The activity of plasma MnSODdepress in individuals with MnSOD AAgeno type.

     

/

返回文章
返回